Left-right asymmetry of striatal dopamine d2 receptors

Nuclear Medicine Communications

Volumn 19, Issue 8, 1998, Pages 781-788

  Larisch, Rolf ^a   Kehren, F ^a   Vosberg, H ^a   Muller Gartner, H W ^a   Klimke, A ^b   Meyer, W ^a  

^a Research Centre jiilich GmbH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR;

ADULT; AGED; ARTICLE; FEMALE; HEMISPHERIC DOMINANCE; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; MALE; MOTOR ACTIVITY; PROTEIN LOCALIZATION; RECEPTOR DENSITY; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; AGING; BENZAMIDES; CEREBELLUM; CORPUS STRIATUM; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PYRROLIDINES; RECEPTORS, DOPAMINE D2; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031658662     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-199808000-00009     Document Type: Article

References (42)

1. Antonini A, Vontobel P, Psylla M Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson’s disease. Arch Neurol 1995; 52: 1183-1190.
2. Berding G, Gratz KF, Kolbe H 123I-IBZM SPECT: Reconstruction methodology and results in parkinsonism and dystonia. Nuklcannediziu 1994; 33: 194-199.
3. Bruecke, T, Podreka I, Angelberger P Dopamine D2 receptor imaging with SPECT: Studies in different neuropsychiatric disorders. I Ccreb Blood Floic Mctab 1991; 11: 220-228.
4. Cordes M, Hierholzer J, Scheloskv L IBZM-SPECT imaging in Parkinson’s disease: Quantification of binding ratios from sequential SPECT measurements in patients and controls. Adv Neurol 1993; 60: 525-528.
5. Haegglund J, Aquilonius SM, Eckernaes SA Dopamine receptor properties in Parkinson’s disease and Huntington’s chorea evaluated by positron emission tomography using llC-N-methyl-spiperone. Acta Neurol Scaud 1987; 75: 87-94.
6. Oertel WH, Schwarz J, Tatsch K IBZM-SPECT as predictor for dopamimetic responsiveness of patients with dc novo parkinsonian syndrome. Adv Neurol 1993; 60: 519-524.
7. Pizzolato G, Chierichetti F, Rossato A Alterations of striatal dopamine D2 receptors contribute to deteriorated response to L-dopa in Parkinson’s disease: A [123I]-IBZM SPET study J Neurnl Transit! 1995; 45: 113-122.
8. Schelosky L, Hierholzer J, Wissel J, Cordes M, Poewe W. Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 1231 IBZM-SPECT. Move Disord 1993; 8: 453-458.
9. Rinne JO, Laihinen A, Ruottinen H et al. Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson’s disease: A PET study with [llC]raclopride. J Neurol Sci 1995; 132: 156-161.
10. Tatsch K, Schwarz J, Oertel WH, Kirsch CM. SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson’s syndrome and Wilson’s disease. Nitcl Med Commun 1991; 12: 699-707.
11. Baron JC, Martinet JL, Cambon H. Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: Correlative evaluation by positron emission tomography and plasma prolactin levels. Psycho-pharmacology (Bed.) 1989; 99: 463-472.
12. Wong DF, Wagner HN Jr, Tune LE Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 1986; 234: 1558-1563.
13. Volk S, Maul FD, Hoer G et al. Dopamine D2 receptor occupancy measured by single photon emission computed tomography with 1231-iodobenzamide in chronic schizophrenia. Psychiatry Res Ncuroimag 1994; 55: 111-118.
14. Klemm E, Grunwald F, Kasper S [123IJIBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics. Am J Psychiatry 1996; 153: 183-160.
15. Hublin C, Launes J, Nikkinen P, Partinen M. Dopamine D2-receptors in human narcolepsy: A SPECT study with 123I-IBZM. Acta Neurol Scaud 1994; 90: 186-189.
16. Khan N, Antonini A, Parkes D et al. Striatal dopamine D2 receptors in patients with narcolepsy measured with PET and IIC-raclopride. Neurology 1994; 44: 2101-2104.
17. Staedt J, Stoppe G, Kogler A et al. [123I]IBZM SPET analysis of dopamine D2 receptor occupancy in narcoleptic patients in the course of treatment. Biol Psychiatry 1996; 39: 107-111.
18. D’haenen HA, Bossuyt A. Dopamine D2 receptors in depression measured with single photon emission computed tomography. Biol Psychiatry 1994; 35: 128-132.
19. Ebert D, Feistel H, Kaschka W, Barocka A, Pirner A. Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation-preliminary results. Biol Psychiatry 1994; 35: 880-885.
20. Ebert D, Feistel H, Loew T, Pirner A. Dopamine and depression-striatal dopamine D2 receptor SPECT before and after antidepressant therapy. Psychopharmacoloni (Bed.) 1996;126:91-94.
21. Larisch R, Klimke A, Vosberg H et al. In vivo evidence for the involvement of dopamine-D2 receptors in striatum and anterior cingulate gyrus in major depression. Neuroimage 1997; 5: 251-260.
22. Larisch R, Schulte KW, Vosberg H, Ruzicka T, Mueller-Gaertner HW. Differential accumulation of 1231-iodobenzamide (IBZM) in melanotic and amelanotic melanoma metastases in vivo. J Nucl Med (in press).
23. Annett M. Left, right, hand and brain: The right shift theory. London: Lawrence Erlbaum Associates, 1970.
24. Greitz T, Bohm C, Holte S, Eriksson L. A computerized brain atlas: Construction, anatomical content, and some applications. J Comp Ass Tomogr 1991; 15: 26-38.
25. Busatto GF, Pilowsky LS, Costa DC et al. Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride-an 123I-IBZM single photon emission tomography (SPET) study. Psychopharmacology (Bed.) 1995; 117: 55-61.
26. Farde L, Wiesel FA, Stone-Elander S et al. D2 dopamine receptors in neuroleptic-naive schizophrenic patients-a positron emission tomography study with [HCJracIopride. Arch Gen Psychiatry 1990; 47: 213-219.
27. Gray NS, Pilowsky LS, Gray JA, Kerwm RW. Latent inhibition in drug naive schizophrenics: Relationship to duration of illness and dopamine D2 binding using SPET. Schizophr Res 1995; 17: 95-107.
28. Laulumaa V, Kuikka JT, Soininen H et al. Imaging of D2 dopamine receptors of patients with Parkinson’s disease using single photon emission computed tomography and iodobenzamide I 123. Arch Neurol 1993; 50: 509-512.
29. Pilowsky LS, Costa DC, Ell PJ Antipsychotic medication, D2 dopamine receptor blockade and clinical response: A 1231 IBZM SPET (single photon emission tomography) study. Psychol Med 1993; 23: 791-797.
30. Verhoeff NP, Kapucu O, Sokole-Busemann E, van Royen EA, Janssen AG. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: Technical and interobserver variability. J Nucl Med 1993; 34: 2076-2084.
31. Antonini A, Leenders KL, Reist H et al. Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and IIC-raclopride. Arch Neurol 1993; 50: 474-480.
32. Hierholzer J, Cordes M, Schelosky L et al. Bestimmung der zerebralen Dopamin-(D2)-Rezeptroen-Dichte mit Hilfe der 123Jod-IBZM-SPECT bei Patienten mit Morbus Parkinson. Rocfo 1992; 157: 390-398.
33. Hierholzer J, Cordes M, Schelosky L et al. Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis. J Nucl Med 1994; 35: 1921-1927.
34. Lobbezoo F, Soucy JP, Montplaisir JY, Lavigne GJ. Striatal D2 receptor binding in sleep bruxism: A controlled study with iodine-123-iodobenzamide and single-photon-emis-sion computed tomography. J Dent Res 1996; 75: 1804-1810.
35. Leenders KL, Hartvig P, Forsgren L et al. Striatal [11CJ-N-methyl-spiperone binding in patients with focal dystonia (torticollis) using positron emission tomography. J Neural Transm Park Dis Dement Sect 1993; 5: 79-87.
36. Pilowsky LS, Costa DC, Ell PJ et al. D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients: An 123I-IBZM single photon emission computerised tomography study. Br J Psychiatry 1994; 164: 16-26.
37. Fricke R, Treinies G. Einführung in die Metaanalyse. Bern: Verlag Hans Huber, 1985.
38. Young LT, Wong DF, Goldman S et al. Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain. Synapse 1991; 9: 188-194.
39. Seeman P, Grigoriadis DE. Dopamine receptors in brain and periphery. Neurocheui bit 1987; 10: 1-25.
40. Chalon S, Guimbal C, Guilloteau D Iodobenzamide for in vivo exploration of central dopamine receptors: Evaluation in animal models of supersensitivity. Life Sei 1990; 47: 729-734.
41. Schneider LH, Murphy RB, Coons EE. Lateralization of striatal dopamine (D2) receptors in normal rats. Neurosei Lett 1982; 33: 281-284.
42. Drew KL, Lyon RA, Titeler M, Glick SD. Asymmetry in D-2 binding in female rat striata. Brain Res 1986; 363: 192-195.